Compare OPK & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPK | PWP |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 1995 | N/A |
| Metric | OPK | PWP |
|---|---|---|
| Price | $1.33 | $17.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | $2.28 | ★ $22.33 |
| AVG Volume (30 Days) | ★ 3.3M | 778.5K |
| Earning Date | 10-29-2025 | 02-06-2026 |
| Dividend Yield | N/A | ★ 1.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | $642,067,000.00 | ★ $757,415,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $38.06 |
| P/E Ratio | ★ N/A | $24.96 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $14.12 |
| 52 Week High | $2.04 | $27.03 |
| Indicator | OPK | PWP |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 39.39 |
| Support Level | $1.29 | $17.25 |
| Resistance Level | $1.37 | $18.35 |
| Average True Range (ATR) | 0.05 | 0.60 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 28.76 | 9.42 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.